Toray Industries, Inc. - Product Pipeline Review - 2014

Published: Sep, 2014 | Pages: 44 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Toray Industries, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Toray Industries, Inc. - Product Pipeline Review - 2014', provides an overview of the Toray Industries, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Toray Industries, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Toray Industries, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Toray Industries, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Toray Industries, Inc.'s pipeline products

Reasons to buy

- Evaluate Toray Industries, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Toray Industries, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Toray Industries, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Toray Industries, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Toray Industries, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Toray Industries, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Toray Industries, Inc. Snapshot 5
Toray Industries, Inc. Overview 5
Key Information 5
Key Facts 5
Toray Industries, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Toray Industries, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Toray Industries, Inc. - Pipeline Products Glance 11
Toray Industries, Inc. - Late Stage Pipeline Products 11
Phase III Products/Combination Treatment Modalities 11
Toray Industries, Inc. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Toray Industries, Inc. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Discovery Products/Combination Treatment Modalities 15
Toray Industries, Inc. - Drug Profiles 16
beraprost sodium LA 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
nalfurafine hydrochloride 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
TRK-170 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
TRK-380 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Small Molecule to Inhibit Dipeptidyl Peptidase IV for Type 2 Diabetes 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Small Molecule to Inhibit p38 MAP Kinase for Undisclosed Indication 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Small Molecule to Inhibit Soluble Epoxide Hydrolase for Chronic Kidney Disease 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Small Molecule to Inhibit Soluble Epoxide Hydrolase for Hypertension 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Small Molecule to Inhibit Vitamin K Epoxide Reductase for Glomerulonephritis 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Small Molecules to Antagonize TRPV1 for Overactive Bladder 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
TRK-390 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Small Molecule to Antagonize CCR3 for Undisclosed Indication 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Toray Industries, Inc. - Pipeline Analysis 31
Toray Industries, Inc. - Pipeline Products by Target 31
Toray Industries, Inc. - Pipeline Products by Route of Administration 33
Toray Industries, Inc. - Pipeline Products by Molecule Type 34
Toray Industries, Inc. - Pipeline Products by Mechanism of Action 35
Toray Industries, Inc. - Recent Pipeline Updates 37
Toray Industries, Inc. - Dormant Projects 38
Toray Industries, Inc. - Company Statement 39
Toray Industries, Inc. - Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Appendix 43
Methodology 43
Coverage 43
Secondary Research 43
Primary Research 43
Expert Panel Validation 43
Contact Us 44
Disclaimer 44

List of Tables
Toray Industries, Inc., Key Information 5
Toray Industries, Inc., Key Facts 5
Toray Industries, Inc. - Pipeline by Indication, 2014 8
Toray Industries, Inc. - Pipeline by Stage of Development, 2014 9
Toray Industries, Inc. - Monotherapy Products in Pipeline, 2014 10
Toray Industries, Inc. - Phase III, 2014 11
Toray Industries, Inc. - Phase II, 2014 12
Toray Industries, Inc. - Phase I, 2014 13
Toray Industries, Inc. - Preclinical, 2014 14
Toray Industries, Inc. - Discovery, 2014 15
Toray Industries, Inc. - Pipeline by Target, 2014 32
Toray Industries, Inc. - Pipeline by Route of Administration, 2014 33
Toray Industries, Inc. - Pipeline by Molecule Type, 2014 34
Toray Industries, Inc. - Pipeline Products by Mechanism of Action, 2014 36
Toray Industries, Inc. - Recent Pipeline Updates, 2014 37
Toray Industries, Inc. - Dormant Developmental Projects,2014 38
Toray Industries, Inc., Other Locations 40
Toray Industries, Inc., Subsidiaries 41